Furthermore, we observed that PC61 treatment enhanced DC/tumor fusion vaccination in a synergistic fashion, and did not abrogate the induction of T-effector cells despite their transient expression of CD25 molecules. This evidence concerns the gene IL2RA and neoplasm.